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To clarify the features and problems presented by a peripheral 
cholangiocarcinoma (CCC), seven patients with hepatectomy from the 
First Department of Surgery, Nagasaki University School of Medicine 
(6 patients), and from Department of Surgery, National Ureshino 
Hospital (one patient) were reviewed. Men predominate with ratio of 
5:2, and an average age was 65.4 years. Tumor location was left lateral 
segment in 4 patients, right lobe, middle lobe and posterior segment in 
one, respectively. Three patients were associated with hepatolithiasis. 
Underlying liver disease was found in 4 patients (57%); cirrhosis in 3 
patients, and chronic hepatitis in one. Initial symptoms were 
abdominal pain, fever and palpable abdominal mass. In imaging 
modalities available, the detection rates of tumor were 100% in CT 
and 67% in US and angiography, respectively. Combination of MRI 
and CT clearly showed tumor characteristics. The serum CEA was 
slightly elevated in 5 patients (83%), but serum CA19-9 rose strikingly 
in 3 patients. Most tumors showed an infiltrating growth along 
intrahepatic bile duct, with a portal vein thrombus and/or satellite 
tumors frequently. In 3 patients, early recurrence with intrahepatic 
metastasis occured within the first 6 months. The patient of poorly 
differentiated adenocarcinoma containing a squamous or signet ring 
cell carinoma showed an extremely poor prognosis. This study 
suggests that early detection of small CCC and an extended resection 
are the most important factors for the survival of patient.
Key Words: Peripheral cholangiocarcinoma, Tumor marker, Imaging 
diagnosis, Liver resection.
Introduction 
Cholangiocarcinoma which arises from the hepatic bile 
duct is uncommon among primary liver tumors, although 
hepatocellular carcinoma (HCC) is not a rare disease in 
Japan." According to the survey conducted by the Liver 
Cancer Study Group of Japan, the histology of 4,765 cases
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of primary liver cancer was analyzed as hepatocellular 
carcinoma in 91.4%, cholangiocellular carcinoma in 5.4%, 
mixed carcinoma in 1.0%, hepatoblastoma in 0.5% and the 
others in 1.8%.2) On the other hand, cholangiocarcinoma 
have been classified into two types: the peripheral type 
originating from the intrahepatic bile duct and the hilar type 
originating from the major hepatic ducts at or near the 
junction of the right and left hepatic duct.'-') In 1990, the 
25th Meeting of Liver Cancer Study Group of Japan 
provided a main theme of intrahepatic cholangiocarcinoma, 
in which the clinical and pathological features were dis-
cussed by many authors." In this Meeting, it was found that 
the numbers of peripheral CCC in most centers were 
between 2 and 18 cases, with lower resectability because of 
advanced stage at operation, a cause of poor prognosis. The 
purpose of this article is to review our experience of 7 
patients with peripheral CCC with particular reference to 
clinical features and pathological factors which might af-
fect the patient's survival.
Patients and Materials 
A total of 7 patients with peripheral CCC who underwent 
hepatectomy at our hospitals were retrospectively re-
viewed. There were 6 patients from the First Department of 
Surgery, Nagasaki University School of Medicine since 
1975, and one patient from the Department of Surgery, 
National Ureshino Hospital in 1993. In accordance with the 
General Rules for the Clinical and Pathological Study of 
Primary Liver Cancer in Japan, the main tumor of CCC 
locating within the liver was difined as peripheral CCC.2j 
All patients were histologically confirmed as cholangio-
cellular carcinoma on the resected specimens. Patients with 
mixed tumors with both elements of HCC and CCC were 
excluded. Clinical and pathological findings were evaluated 
on the basis of the General Rules for the Clinical and 
Pathological Study of Primary Liver Cancer or on Cancer
of Biliary Tract in Japan.' 3)
Results 
Clinical features 
There were 5 men and 2 women ranging from 56 to 79 
years of age, with an average of 65.4 years. Primary sites 
of the tumor were the lateral segment in 4 patients, and the 
right lobe, the middle lobe and the posterior segment in 
one, respectively. Peripheral CCC associated with hepatoli-
thiasis was found in 3 patients (Table 1). Initial symptoms 
and physical findings were usually nonspecific. Five pa-
tients presented with abdominal pain and/or fever, two 
patients had a palpable mass, and one patient was detected 
the tumor during follow-up examination for underlying 
liver disease (Case 3). One patient was diagnosed during 
operation for gastric ulcer (Case 1). No patient had jaun-
dice or gallstone disease. 
Imaging Modalities 
The detection for tumor by ultrasonography (US), com-
puted tomography (CT) and angiography are shown in 
Table 1. For peripheral CCC, CT had the highest detection 
rate (100%) compared with angiography and US (67%, 
respectively). In 2 patients associated with hepatolithiasis, 
it was difficult to detect the tumor by US. The MRI 
examination was performed for the recent case (Case 7). 
The tumor was shown as an irregular central hypointensity 
on T1-weighted imaging and as a hyperintensity with an 
irregular central area of hypointensity on T2-weighted 
imaging (Fig. 1). One patient (Case 2) was histologically 
comfirmed cholangiocarcinoma by US-guided needle 
biopsy. 
Tumor markers 
The values of serum AFP, CEA, CA19-9 and HBsAg of 
patients are tabulated in Table 2. In 5 out of 6 patients
(83%), the serum CEA value was maderately elevated. 
Three patients showed a remarkable rise of serum CA19-9 
more than 1,000U/mI. Only one patient (Case 2) had 
abnormal serum AFP levels with 1,365ng/ml. None had 
positive serum HBsAg.
Fig. 1. Sagital Ti-weighted MR imaging of peripheral CCC in 
Case 7 showing 7.0 X 4.2cm low-intensity area in middle lobe 
(above). Also mass on transverse T2-weighted MR imaging was 
high-intensity, with an irregular central area of hypointensity 
(below).
Table 1. Clinical Features of Cholangiocarcinoma
    No. 1 2 3 4 5 6 7 
  Age, Sex 56-M 61 •M 61-M 60-F 67-F 79-M 69-M 
 Tumor 
 Location L P L L PA L M 
  Stone - - - + + + -
 US ND + + NR + NR + 
 CT-scan ND + + + + + + 
 Angiography + + + ND + NR NR 
 Resection HR2 (L, M) HRI (P) HRI (L) HR1 (L) HR1 (P) HRI (L) HR1 (M) 
                                                             CBD 
 Survival 6M died 3M died 9M died 3Y1I M died 3M died 7M died 7M alive 
ND: not done, NR: not remarkable, +: positive findings
Table 2. Laboratory Findings on Admission
    No. 1 2 3 4 5 6 7 
  Age, Sex 56•M 61 •M 61 •M 60•F 67•F 79•M 69•M 
 AFP ng/ml 4.0 1,365 5.0 3.8 1.0 5.7 1.3 
 CEA ng/ml ND 6.6 2.9 1.9 4.1 5.1 4.7 
 CAI 9-9 U/ml ND 35 31 ND 3,363 1,204 2,600 
 HBS-Ag ND - - - - - -
 HBs-Ab ND - - + - + -
ND: not done
Pathologic Features 
Pathologic findings of the tumors removed at operation are 
summarized in Table 3. Four out of 7 patients (57%) had 
underlying liver diseases; chronic hepatitis in one (14%); 
and cirrhosis in 3 (43%). But, none had severe cirrhosis. 
The remaining 3 patients showed the normal liver. The 
maximum diameter of tumors ranged from 2.0cm to 
13.0cm. Following classification of the macroscopic distri-
bution of the primary liver cancer, there were 5 patients of 
"massive"
, one patient of "nodular" and the other one of 
"multinodular"
, of which 6 patients demonstrated infil-
trating growth along intrahepatic bile duct (Fig. 2 and 3). 
Only one patient had the thinly encapsulated tumor which 
showed expanding growth. The histology of tumor was 
well differentiated adenocarcinoma in 4 patients, moder-
ately differentiated adenocarcinoma in one, and poorly 
differentiated adenocarcinoma in 2. However, in a part of 
the region of poorly differentiated adenocarcinoma, a com-
ponent of signet ring cell or adenosquamous cell carcinoma 
was observed. Microscopically, the presence of tumor 
thrombus in small portal branches (Vp,) was observed in 5 
patients (71 %).
Table 3. Pathological Findings of Tumor
      No. 1 2 3 4 5 6 7 
    Age, Sex 56•M 61 •M 61 •M 60•F 67•F 79•M 69•M 
 Tumor size (cm) 5x6 10X 10 2.2x2 4.5x3 13x8 7x3.5 7x4.2 
 Growth form massive multiple single massive massive massive massive 
                                  nodular nodular 
  S S1 S2 S, S2 S1 S1 s, 
 vp 1 1 0 1 1 1 0 
 IM IM, IM2 IM, IM, IM, IMa IM, 
 P Pa P, Pa Po Pa Po Pa 
 Cell 
 differentiation well poorly moderate well poorly well well 
                    pap sig as 
 Stage III III II III III III III 
 Noncancerous 
 tissue LC LC LC NC NC CH NC 
NC: noncirrhotic liver, CH: chronic hepatitis, LC: liver cirrhosis, pap: papillary, sig: signet ring cell, as: adenosquamous.
Fig. 2. Cut surface of peripheral CCC in Case 3 showing 2.2 x 
2cm grey-white tumor which infiltrates along the intrahepatic bile 
duct (arrow).
Fig. 3. Histological findings in Case 6 showing periductal inva-
sion of CCC (H. E. X 36).
Operation and Survival 
All main tumors of 7 patients were surgically removed 
(Table 1). In one patient (Case 7) who underwent middle 
hepatic lobectomy, a satellite tumor infiltrating the middle 
hepatic vein was left in place. This satellite nodule was 
repeatedly treated by transhepatic Ethanol injection therapy 
(PEIT) after surgery. He is still alive 7 months after opera-
tion. The operations were considered radical in 6 patients 
judged by intraoperative findings and US or CT. Two of 
these patients died of cancer-unrelated diseases; hepatic 
failure in Case 1 and suicide in Case 3. There were 3 
recurrences after surgical treatment (Case 2, 4 and 6), i. e., 
an incidence of 42.9%. Among them, 2 patients with poorly 
differentiated adenocarcinoma had early recurrence of re-
sected margin and/or intrahepatic matastasis at the first one 
month, who died 3 and 7 postoperative months, respec-
tively (Case 2 and 6). In Case 2, the tumor of posterior 
segment showed dense adhesion to parietal peritoneum 
with milliary dissemination surrounding it (P1), that was 
considered to be disseminated by preoperative needle 
biopsy. In patient (Case 4) with well differentiated adeno-
carcinoma, intrahepatic metastasis was observed at 6 
months postoperatively. She was alive with cancer for 3.5 
years. The patient with right lobectomy subsequently de-
veloped hepatic failure because of cirrhosis, following 
uneventful course despite medication (Case 1).
Discussion 
It has been generally agreed that the tumor-associated 
symptoms in the patient with peripheral CCC were uncom-
mon even in advanced stage, a cause of poor prognosis."' 
In the present series, unusual presentations, such as a 
palpable abdominal mass, intractable pain, fever and peri-
odic follow-up examination for their underlying liver dis-
ease led to tumor detection. 
  Serum CEA and CA19-9 measurements have been fre-
quently the useful screening test of CCC to differentiate 
from HCC. In Japan series, the positive rate of CEA for 
cholangiocarcinoma was 42.7%.9' However, there was none 
of our patient whose serum CEA measurement was the first 
diagnostic clue for CCC, although serum CEA values in 
83% of the patients were moderately elevated. Therefore, 
the utility of serum CEA measurement for CCC has some 
limitation. An extremely high elevation of serum CA19-9 
level higher than 1,000U/ml was found in our 3 patients in 
agreement with other reports with high frequency ranging 
from 70% to 80%.6' This suggested that serum CA19-9 
measurement might be useful as a screening test for periph-
eral CCC. The elevation of serum AFP level were occa-
sionally observed. In our series, only one patient showed a 
remarkable rise of serum AFP higher than 1,000ng/ml. 
Japan series described similar cases in 6.4% among 205
cholangiocarcinoma.3) Thus, initial and laboratory abnor-
malities are generally minimal with this tumor, so that the 
role of imaging procedures for diagnosis of the tumor is 
important. 
 According to Japan series, the detection rates for cholan-
giocarcinoma by US, CT and angiography were described 
as 92%, 94% and 83%, respectively. 12' However, US or CT 
findings of peripheral CCC have previously been described 
as somewhat nonspecific. This tumor usually manifests as a 
low-attenuation homogeneous mass with irregular mar-
gin."' Recently, the useful information of MR imaging on 
peripheral cholangiocarcinoma have been published in 
several articles. '° 12) Tani et al, in a prospective study com-
paring CT and MR imaging on the patients with this tumor, 
indicated that MR (long TR/TE SE) imaging was the most 
effective initial screening method in demonstrating the 
presence and determining resectability. 12) 
 Cholangiocarcinoma associated with hepatolithiasis was 
uncommon, ranging from 1.5 to 9.4% among hepatoli-
thiasis.13' This tumor usually occurs in the left intrahepatic 
duct. However, the diagnosis is very difficult. In one of our 
patients, the tumor was overlooked because images of US 
and CT were insufficient to demonstrate the mass due to 
the coexistence of stones. The possibility of existence of 
peripheral CCC should still be kept in mind even if the 
preoperative examination of hepatolithiasis is negative for 
associated carcinoma. On the other hand, underlying liver 
disease was present in 4 of our patients, a figure much 
lower than for HCC and in agreement with Japan series 
with incidence of 9.9% fibrosis and 14% cirrhosis.2' 
  Most peripheral CCC, regardless of their cause, develop 
in the small bile ducts and grow in a nodular, massive, or 
diffuse pattern with early infiltration into the hepatic paren-
chyma. Although the process of this morphogenesis differs 
from that of HCC, several important pathologic features of 
this tumor affecting the prognosis have been pointed out. 
These include the growth pattern infiltrating along intra-
hepatic duct, the direct invasion to portal vein branches, the 
infiltration into surrounding nerves, lymphatic metastasis 
clustered along hepatic arteries and/or celiac arteries, and 
the presence of satellite tumors.In this series, we 
confirmed histologically these factors by the analysis of the 
resected specimens. 
 For hepatic resection of peripheral CCC, the important 
factors are these pathological features. However, the prog-
nosis is still extremely poor despite curative resection.6' 
Three patients (43%) of our series subsequently developed 
recurrences at resected margin and/or intrahepatic metas-
tasis within 6 months after operation. Especially, early 
recurrence was observed in 2 patients with poorly differ-
entiated adenocarcinoma containing a component of signet 
ring cell carcinoma or adenosquamous cell carcinoma. 
Nakajima, et al. reported a poor prognosis of the patient 
with cholangiocarcinoma containing a component of squa-
mous or adenosquamous cell carcinoma. 16) It seems that the
poorly differentiated adenocarcinoma with these compo-
nents may lead to rapid dissemination of the disease result-
ing in death within a short period of time as has been noted 
for some other human tumors. 
 Attitudes to operation on the liver tumor have changed in 
recent years, and results have improved with better faci-
lities for intensive care and introduction of new technology. 
However, the curative resection rate for peripheral CCC 
have been reported to be lower than that for HCC by many 
centers. According to Japan series, 86 out of 234 cases 
(36.8%) with resection for CCC were curative, whereas the 
curative resection rate for HCC was 55.1 % (2,189 out of 
4,152 cases)." This was attributed to advanced stage of the 
lesion due to delayed diagnosis, and the technical difficult 
for sufficient resection at tumor margin because of the 
infiltration of cancer cells along intrahepatic bile duct. In 
conclusion, early detection of small peripheral CCC and an 
adequate hepatic resection including extensive lobectomy 
for noncirrhotic liver are most important for the excellent 
prognosis of the patients.
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